Dechra Pharmaceuticals reports rising pet spending...but its shares fall
By Chris Bailey | Monday 6 September 2021
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I have written a few times, most recently HERE, about the ‘development and marketing of veterinary products’ company Dechra Pharmaceuticals (DPH). Whilst I remember being very impressed by it many years ago when it listed, I concluded back in late February that it may have said ‘thanks to the love of dogs (and Brexit fears)’ but it did not work for me. Since then the stock has pushed up even further although – as noted last week – insufficiently to join the FTSE-100. And the shares are down by more than 7% as I write, so what is going on?
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.